DRI Healthcare Trust (FRA:3IJ0) ROCE %: % (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3IJ0 DRI Healthcare Trust FRA:3IJ0
55 GF Score
Price €10.64
GF Value €11.47
! 6 Warning Signs
View Full Analysis

What is DRI Healthcare Trust ROCE %?

DRI Healthcare Trust FRA:3IJ0 -1.02% 55 ROCE % is % as of Mar. 2026. GuruFocus rates FRA:3IJ0 with a GF Score™ of 55/100 and a GF Value™ of €11.47. The stock has 6 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

FRA:3IJ0
55GF Score
DRI Healthcare Trust FRA:3IJ0
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
DRI Healthcare Trust (FRA:3IJ0) has a ROCE % of % as of Mar. 2026.
Is DRI Healthcare Trust's ROCE % too high?
DRI Healthcare Trust's current ROCE % is %. Overall, DRI Healthcare Trust has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does DRI Healthcare Trust's ROCE % compare to ZTS and UTHR?
DRI Healthcare Trust's ROCE % of % can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.04, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DRI Healthcare Trust's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DRI Healthcare Trust stock overvalued right now?
DRI Healthcare Trust (FRA:3IJ0) has a current ROCE % of %. The stock's GF Value™ is €11.47, compared to a current price of €10.64 — trading 7.3% below its estimated fair value. The current ROCE % is %. DRI Healthcare Trust's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For DRI Healthcare Trust (FRA:3IJ0), the current ROCE % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DRI Healthcare Trust (FRA:3IJ0) Overvalued in 2026?

Based on GuruFocus' analysis, DRI Healthcare Trust stock appears to be undervalued. The current stock price of €10.64 is trading 7.3% below its estimated GF Value™ of €11.47.

Key valuation signals for FRA:3IJ0:

  • ROCE %: %
  • GF Value™: €11.47 vs. price of €10.64 (7.3% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the FRA:3IJ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DRI Healthcare Trust Business Description

Address 100 King Street West, 1 First Canadian Place, Suite 6200, Toronto, ON, CAN, M5X 1B8
DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.
55GF Score

Get the complete analysis for FRA:3IJ0

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.64
Price
€11.47
GF Value